MSB 3.19% 97.0¢ mesoblast limited

CLBP - cost/benefit ratio for such an expensive treatment. Not...

  1. 405 Posts.
    lightbulb Created with Sketch. 39
    CLBP - cost/benefit ratio for such an expensive treatment. Not sure it will ever get FDA. What is the cost of treatment...CLBP has significant impact on quality of life, but not sure insurance companies would be willing to reimburse the costs. I had hopes for ARDS trial but i feel they stuffed the trial design
    Hugely disappointed. Enjoy your R&R
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
97.0¢
Change
0.030(3.19%)
Mkt cap ! $1.107B
Open High Low Value Volume
94.0¢ 98.0¢ 92.0¢ $3.342M 3.477M

Buyers (Bids)

No. Vol. Price($)
4 33313 97.0¢
 

Sellers (Offers)

Price($) Vol. No.
97.5¢ 73982 2
View Market Depth
Last trade - 16.10pm 03/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.